VOI - Voice of Indonesia | RRI - Radio Republik Indonesia

The development of systemic therapy in the treatment of cancer has progressed rapidly in recent years. New drugs, both chemotherapy and targeted therapy, continue to emerge. The development of this massive information cannot all be recorded in the memory of the doctors. That's why, on June 25, the Indonesian Association of Oncological Surgeons launched the ISTRY Application. According to Chairman of the Indonesian Association of Oncological Surgeons, Walta Gautama, ISTRY is a part of the contribution of the Indonesian Association of Oncological Surgeons for cancer treatment in Indonesia. This is the first smart device application in Indonesia that can provide information for doctors to make clinical decisions in the field of systemic cancer therapy.

ISTRY is an android-based paid mobile application that provides an interactive platform for medical personnel to obtain information about the latest cancer therapies circulating in Indonesia, especially breast cancer, thyroid cancer, head-and-neck cancer, soft tissue cancer, skin cancer, and lymphoma. ISTRY Project Manager, Febriyanto Kurniawan said that the target users of ISTRY are surgeon oncology, oncology hematologists, and general surgeons who treat cancer patients. Furthermore, Febriyanto also said that with the ISTRY application, doctors can directly calculate the dose of chemotherapy drugs, hormonal drugs, and other cancer therapy supporting drugs. This will greatly facilitate the doctor and increase the accuracy of therapy, which will ultimately benefit patients. This application also features information on how to give/administer drugs as well as data on side effects of chemotherapy drugs and targeted therapy.

In appearance, the application is very easy to use. To be able to use it, someone only needs to download it from the appstore. In it, there are various features about cancer therapy that can be accessed by application users. This application will also be evaluated and updated every 2 years to ensure the accuracy and update information. Doctor Walta hopes that in the future, the ISTRY 1.0 application can be a guide for improving cancer therapy in Indonesia. In addition, it can also be developed in other cancer therapies, such as oncology surgery.